Danaher (NYSE: DHR) raises EPS guide after profit and cash flow climb

Posted by Stacy Sanders on Oct 21st, 2026

What happened

Danaher Corporation (NYSE: DHR) said third-quarter net earnings rose 34.5% to $1.2 billion on October 21, 2026. Revenue increased 8.5% to $6.6 billion. Operating cash flow was $1.9 billion, and non-GAAP free cash flow was $1.6 billion. Operating profit rose to $1.25 billion from $1.15 billion a year earlier.

Non-GAAP adjusted diluted EPS rose 11.5% to $2.11. Core sales excluding respiratory revenue rose 5.5%, and core sales rose 3.0%. For the first nine months, revenue rose to $18.77 billion from $17.73 billion. Free cash flow from continuing operations rose to $3.98 billion from $3.52 billion. Nine-month operating profit rose to $3.72 billion from $3.19 billion.

Key numbers

Metric	Latest	Change	Source
Net earnings	$1.2 billion	from $908 million, +34.5%	SEC 8-K exhibit 99.1
Revenue	$6.6 billion	from $6.1 billion, +8.5%	SEC 8-K exhibit 99.1
Operating cash flow	$1.9 billion	from $1.66 billion, +13.5%	SEC 8-K exhibit 99.1
Non-GAAP free cash flow	$1.6 billion	from $1.37 billion, +19.0%	SEC 8-K exhibit 99.1
Non-GAAP adjusted diluted EPS	$2.11	from $1.89, +11.5%	SEC 8-K exhibit 99.1
Full-year 2026 adjusted diluted EPS guidance	$8.57 to $8.62		SEC 8-K exhibit 99.1

Why it matters

OptimistFi's case is that Danaher turns installed-base demand in diagnostics and life-science instruments into predictable cash that management can compound with DBS and acquisitions. This filing supports that view because revenue, earnings and cash flow all improved, and the company raised its full-year EPS guide. Operating cash flow also topped net earnings, which fits that cash-conversion pattern.

The low end of full-year adjusted EPS guidance moved up by $0.12, from $8.45 to $8.57. That is a positive sign. Still, the fourth quarter includes an approximately 150 basis point respiratory headwind. Management also says tariffs, currency, and acquisition integration can affect future results. Nine-month operating cash flow reached $4.74 billion, up from $4.3 billion a year earlier.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

Danaher will discuss the quarter and its outlook on a conference call today at 8:00 a.m. ET. A replay will be available on the Investors section of Danaher's website until November 4, 2026. Investors will watch whether core revenue excluding respiratory revenue lands in the 4.0% to 5.0% range and whether full-year EPS stays within the new guide.

Stronger core growth and another guide lift would support the case. A miss on that range or a wider respiratory drag would weaken it. The call will also show whether management keeps the same demand tone behind the outlook.